Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus.
Level 5 - mechanism / opinion, no new human data
Consensus statement and practice guideline
PubMed 20584218 · doi:10.1111/j.1742-1241.2010.02410.x
What was done
An expert panel developed evidence-based consensus recommendations on the link between erectile dysfunction (ED) and coronary artery disease (CAD). The guidance outlines cardiovascular risk stratification, screening protocols (including blood pressure, fasting lipids, fasting glucose, and testosterone), risk factor modification, and medical management using PDE5 inhibitors and testosterone replacement.
What was found
The panel noted that ED symptoms typically precede CAD symptoms by an estimated 2 to 3 years and cardiovascular events by 3 to 5 years. ED is noted to associate with more severe CAD and increased all-cause and cardiovascular mortality. Clinical recommendations prioritize cardiovascular stabilization and aggressive treatment of hypertension, diabetes, and hyperlipidaemia prior to or alongside ED management with PDE5 inhibitors. Aside from these estimated time intervals, the abstract provides no specific quantitative effect sizes or primary trial data.
Why it matters
This consensus establishes erectile dysfunction as an early warning sign for occult cardiovascular disease, identifying a critical multi-year window for cardiovascular evaluation and risk reduction.
Limits
This is a consensus guidance document rather than an original empirical study or systematic review. The abstract does not report specific primary participant counts, study inclusion criteria, effect sizes, or confidence intervals.
Cited by
- supports Men with organic erectile dysfunction typically develop cardiac issues within 3 to 5 years, and 14% have a heart attack within 7 years.